Class information for:
Level 1: VENLAFAXINE//MILNACIPRAN//ESCITALOPRAM

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
8771 1150 35.4 71%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
667 12573 ANTIDEPRESSANTS//AGOMELATINE//MOCLOBEMIDE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 VENLAFAXINE Author keyword 50 24% 16% 185
2 MILNACIPRAN Author keyword 38 37% 7% 84
3 ESCITALOPRAM Author keyword 35 24% 11% 126
4 DULOXETINE Author keyword 26 20% 10% 117
5 DESVENLAFAXINE Author keyword 24 52% 3% 32
6 R CITALOPRAM Author keyword 15 82% 1% 9
7 INT HLTH ECON EPIDEMIOL Address 12 86% 1% 6
8 O DESMETHYLVENLAFAXINE Author keyword 12 59% 1% 13
9 DULOXETINE HYDROCHLORIDE Author keyword 7 48% 1% 11
10 VENLAFAXINE XR Author keyword 6 42% 1% 11

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 VENLAFAXINE 50 24% 16% 185 Search VENLAFAXINE Search VENLAFAXINE
2 MILNACIPRAN 38 37% 7% 84 Search MILNACIPRAN Search MILNACIPRAN
3 ESCITALOPRAM 35 24% 11% 126 Search ESCITALOPRAM Search ESCITALOPRAM
4 DULOXETINE 26 20% 10% 117 Search DULOXETINE Search DULOXETINE
5 DESVENLAFAXINE 24 52% 3% 32 Search DESVENLAFAXINE Search DESVENLAFAXINE
6 R CITALOPRAM 15 82% 1% 9 Search R+CITALOPRAM Search R+CITALOPRAM
7 O DESMETHYLVENLAFAXINE 12 59% 1% 13 Search O+DESMETHYLVENLAFAXINE Search O+DESMETHYLVENLAFAXINE
8 DULOXETINE HYDROCHLORIDE 7 48% 1% 11 Search DULOXETINE+HYDROCHLORIDE Search DULOXETINE+HYDROCHLORIDE
9 VENLAFAXINE XR 6 42% 1% 11 Search VENLAFAXINE+XR Search VENLAFAXINE+XR
10 ANTIDEPRESSANT EFFICACY 5 44% 1% 8 Search ANTIDEPRESSANT+EFFICACY Search ANTIDEPRESSANT+EFFICACY

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 WY 45 030 80 90% 3% 35
2 MIDALCIPRAN 58 92% 2% 23
3 PAROXETINE CONTROLLED TRIAL 43 69% 3% 37
4 O DESMETHYLVENLAFAXINE 42 74% 3% 31
5 100 MG DAY 39 80% 2% 24
6 Z HYDROCHLORIDE 27 92% 1% 11
7 4TH GENERATION ANTIDEPRESSANT 23 86% 1% 12
8 F 2207 21 90% 1% 9
9 DESMETHYLVENLAFAXINE 20 100% 1% 9
10 EXTENDED RELEASE XR 20 49% 3% 29

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis 2009 538 105 42%
Duloxetine Clinical Pharmacokinetics and Drug Interactions 2011 39 49 63%
Comparative Benefits and Harms of Second-Generation Antidepressants for Treating Major Depressive Disorder An Updated Meta-analysis 2011 69 114 30%
Levomilnacipran for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed? 2013 11 19 63%
A systematic review of duloxetine and venlafaxine in major depression, including unpublished data 2011 20 78 73%
Is the significant superiority of escitalopram compared with other antidepressants clinically relevant? 2009 37 17 82%
Efficacy of escitalopram compared to citalopram: a meta-analysis 2011 13 19 95%
Escitalopram for the management of major depressive disorder: a review of its efficacy, safety, and patient acceptability 2012 11 41 80%
Which antidepressants have demonstrated superior efficacy? A review of the evidence 2007 71 30 67%
Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents 2007 132 96 40%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 INT HLTH ECON EPIDEMIOL 12 86% 0.5% 6
2 GLOBAL PHARMACOKINET PHARMACODYNAM TRIAL SIMULAT 3 100% 0.3% 3
3 MEDICOPSYCHOL B 3 60% 0.3% 3
4 ABT MED WISSEN 2 67% 0.2% 2
5 ECON PRICING 2 67% 0.2% 2
6 ENSINO PESQUISA CONTROLE QUALIDADE MEDICAME 1 100% 0.2% 2
7 GLOBAL OUTCOMES HLTH TECHNOL ASSESSMENT 1 50% 0.2% 2
8 INSERMEA 512 1 100% 0.2% 2
9 INT CONSORTIUM MOOD PSYCHOT DISORDERS 1 50% 0.2% 2
10 MED ABT NEUROL PSYCHIAT 1 100% 0.2% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000230454 MIRTAZAPINE//ORG 3770//C 11MIRTAZAPINE
2 0.0000220803 LITHIUM AUGMENTATION//RESISTANT DEPRESSION//DEP S CLIN PROGRAM
3 0.0000219240 NORFLUOXETINE//FLUVOXAMINE//CITALOPRAM
4 0.0000171340 REBOXETINE//SELECTIVE NOREPINEPHRINE REUPTAKE INHIBITOR//SELECTIVE NRI
5 0.0000136836 PINDOLOL//VILAZODONE//NEUROBIOL PSYCHIAT UNIT
6 0.0000135127 AGOMELATINE//MELATONERGIC RECEPTORS//S 20098
7 0.0000120892 PAINFUL PHYSICAL SYMPTOMS//PAIN DEPRESSION DYAD//INTERCONTINENTAL INFORMAT SCI
8 0.0000104789 BROMATOL NUTR DIETET//ESTADES PRACT TUTELADES UNIT//CLIN PHARMACOL MED CARE
9 0.0000103157 MAJOR DEPRESSION INVENTORY//FREDERIKSBORG GEN HOSP//MELANCHOLIA SCALE
10 0.0000102623 ATOMOXETINE HYDROCHLORIDE//4 HYDROXYATOMOXETINE//ANTI DEPRESSANT DRUG